164 related articles for article (PubMed ID: 21719441)
21. Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study.
Stiller CA; Benjamin S; Cartwright RA; Clough JV; Gorst DW; Kroll ME; Ross JR; Wheatley K; Whittaker JA; Taylor PR; Proctor SJ
Br J Cancer; 1999 Feb; 79(3-4):658-65. PubMed ID: 10027346
[TBL] [Abstract][Full Text] [Related]
22. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
23. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
24. [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87].
Steinbach D; Dörffel W; Eggers G; Holfeld E; Kluba U; Krause I; Lauterbach I; Reiss T; Rieske K; Scharfe V; Schumacher R; Weigel H; Weinmann G; Zintl F; Hermann J
Klin Padiatr; 2001; 213(4):162-8. PubMed ID: 11528549
[TBL] [Abstract][Full Text] [Related]
25. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G
Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
27. Serotype-specific pneumococcal antibody concentrations in children treated for acute leukaemia.
Patel SR; Bate J; Borrow R; Heath PT
Arch Dis Child; 2012 Jan; 97(1):46-8. PubMed ID: 20705722
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcome of adolescents with acute lymphoblastic leukemia.
Irken G; Oren H; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Uysal K; Cevik N
Ann Hematol; 2002 Nov; 81(11):641-5. PubMed ID: 12454702
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
30. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
31. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
32. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
34. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.
Rubnitz JE; Lensing S; Zhou Y; Sandlund JT; Razzouk BI; Ribeiro RC; Pui CH
Cancer; 2004 Oct; 101(7):1677-84. PubMed ID: 15378506
[TBL] [Abstract][Full Text] [Related]
35. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
[TBL] [Abstract][Full Text] [Related]
36. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
37. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
Attarbaschi A; Mann G; Dworzak M; Urban C; Fink FM; Dieckmann K; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Feb; 114(4):148-57. PubMed ID: 12060981
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Down's syndrome with acute leukaemia.
Levitt GA; Stiller CA; Chessells JM
Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
[TBL] [Abstract][Full Text] [Related]
40. [An analysis of prognostic factors for acute leukemia patients with 5-year long-term survival in Shanghai].
Wang X; Lin G; Wang J; Wang Q; Lin P
Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):827-31. PubMed ID: 11798727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
